Proliferative	O
diabetic	O
retinopathy	O
is	O
associated	O
with	O
a	O
low	O
level	O
of	O
the	O
natural	O
ocular	B-Organ
anti	O
-	O
angiogenic	O
agent	O
pigment	O
epithelium	O
-	O
derived	O
factor	O
(	O
PEDF	O
)	O
in	O
aqueous	B-Organism_substance
humor	I-Organism_substance
.	O

a	O
pilot	O
study	O
.	O

Retinopathy	O
is	O
the	O
most	O
common	O
microvascular	B-Tissue
diabetes	O
complication	O
and	O
represents	O
a	O
major	O
threat	O
to	O
the	O
eyesight	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
address	O
the	O
role	O
of	O
pro	O
-	O
and	O
anti	O
-	O
angiogenic	O
molecules	O
in	O
diabetic	O
retinopathy	O
in	O
the	O
aqueous	B-Organism_substance
humor	I-Organism_substance
of	O
the	O
eye	B-Organ
.	O

Aqueous	B-Organism_substance
humor	I-Organism_substance
was	O
collected	O
at	O
cataract	O
surgery	O
from	O
19	O
diabetic	O
patients	O
and	O
from	O
13	O
age	O
-	O
and	O
sex	O
-	O
matched	O
normoglycemic	O
controls	O
.	O

Levels	O
of	O
pro	O
-	O
angiogenic	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
and	O
angiogenic	O
inhibitor	O
pigment	O
epithelium	O
-	O
derived	O
factor	O
(	O
PEDF	O
)	O
were	O
determined	O
.	O

Angiogenic	O
activity	O
of	O
the	O
aqueous	B-Organism_substance
humor	I-Organism_substance
was	O
quantified	O
by	O
measuring	O
its	O
effect	O
on	O
the	O
migration	O
of	O
capillary	B-Cell
endothelial	I-Cell
cells	I-Cell
.	O

In	O
the	O
aqueous	B-Organism_substance
fluid	I-Organism_substance
,	O
VEGF	O
levels	O
were	O
increased	O
in	O
diabetics	O
(	O
mean	O
values	O
:	O
501	O
vs	O
.	O
367	O
pg	O
/	O
ml	O
;	O
p	O
=	O
0	O
.	O
05	O
)	O
,	O
compared	O
to	O
controls	O
.	O

PEDF	O
was	O
found	O
to	O
be	O
decreased	O
in	O
diabetics	O
(	O
mean	O
values	O
:	O
2080	O
vs	O
.	O
5780	O
ng	O
/	O
ml	O
;	O
p	O
=	O
0	O
.	O
04	O
)	O
compared	O
to	O
controls	O
.	O

In	O
seven	O
diabetic	O
patients	O
with	O
proliferative	O
retinopathy	O
,	O
the	O
most	O
profound	O
finding	O
was	O
a	O
significant	O
decrease	O
of	O
the	O
PEDF	O
level	O
(	O
mean	O
value	O
:	O
237	O
ng	O
/	O
ml	O
)	O
,	O
whereas	O
VEGF	O
levels	O
were	O
comparable	O
to	O
diabetic	O
patients	O
without	O
proliferation	O
(	O
mean	O
value	O
:	O
3153	O
;	O
p	O
=	O
0	O
.	O
003	O
)	O
.	O

Angiogenic	O
activity	O
in	O
samples	O
of	O
patients	O
from	O
the	O
control	O
group	O
was	O
generally	O
inhibitory	O
due	O
to	O
PEDF	O
,	O
and	O
inhibition	O
was	O
blocked	O
by	O
neutralizing	O
antibodies	O
to	O
PEDF	O
.	O

Likewise	O
,	O
in	O
diabetics	O
without	O
proliferation	O
,	O
angiogenic	O
activity	O
was	O
also	O
blocked	O
by	O
antibodies	O
to	O
PEDF	O
.	O

We	O
will	O
demonstrate	O
here	O
that	O
the	O
level	O
of	O
the	O
natural	O
ocular	B-Organ
anti	O
-	O
angiogenic	O
agent	O
PEDF	O
is	O
inversely	O
associated	O
with	O
proliferative	O
retinopathy	O
.	O

PEDF	O
is	O
an	O
important	O
negative	O
regulator	O
of	O
angiogenic	O
activity	O
of	O
aqueous	B-Organism_substance
humor	I-Organism_substance
.	O

Our	O
data	O
may	O
have	O
implications	O
for	O
the	O
development	O
of	O
novel	O
regimens	O
for	O
diabetic	O
retinopathy	O
.	O

